To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4551 | S1r-in-10 |
Novel selective sigma 1 receptor (S1R) antagonist, exhibiting potent binding affinity for S1R, high selectivity over S2R and 87 other human targets, acceptable in vitro metabolic stability, slowing clearance in liver microsomes, and excellent blood-brain
More description
|
|
| DCC4550 | S1pr4-agonist-5c |
Novel potent and selective agonist activity for S1PR4
More description
|
|
| DCC4549 | S18616 Hydrochloride |
Selective and highly potent alpha2-adrenoceptor agonist
More description
|
|
| DCC4548 | S18327 |
Novel, Potential Antipsychotic Displaying Marked Antagonist Properties at α1- and α2-Adrenergic Receptors
More description
|
|
| DCC4547 | S-18326 |
Potent and selective thrombin inhibitor for the treatment of thromboembolic disorders
More description
|
|
| DCC4546 | s17834 |
Inhibitor of NADPH oxidase, preventing the structural and functional sequelae of diet-induced metabolic heart disease
More description
|
|
| DCC4545 | S15535 |
Potent, orally active, partial 5-HT1A receptor agonist
More description
|
|
| DCC4544 | S14671 |
Potent 5-HT1A receptor agonist, also acting as a 5-HT2A and 5-HT2C receptor antagonist
More description
|
|
| DCC4543 | s14161 |
Novel inhibitor of D-cyclin transactivation via phosphoinositide 3-kinase pathway
More description
|
|
| DCC4542 | S-1360 |
Novel HIV-1 integrase inhibitor
More description
|
|
| DCC4541 | S-1033 |
FP receptor agonist
More description
|
|
| DCC4540 | S07662 |
Inverse agonist of the constitutive androstane receptor (CAR)
More description
|
|
| DCC4539 | S06-1031 |
Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection
More description
|
|
| DCC4538 | S06-1011 |
Highly Potent and Selective Butyrylcholinesterase (BChE) Inhibitor for Cognitive Improvement and Neuroprotection
More description
|
|
| DCC4537 | S05014 |
Novel highly effective tyrosinase inhibitor with great potential to be utilized in anti-Parkinsonian syndrome
More description
|
|
| DCC4536 | S007-1558 |
The most viable GPVI modulator, acting as a potent antithrombotic agent
More description
|
|
| DCC4535 | S(+)-o-desmethylraclopride Hbr |
Selective D2 dopamine receptor antagonist; Precursor to radiolabeled S-(-)-raclopride
More description
|
|
| DCC4534 | S(-)-8-hydroxy-dpat Hydrobromide [78095-20-2] |
Partial 5-HT1A serotonin receptor agonist
More description
|
|
| DCC4532 | Rxfp3/4-agonist-1 |
The first Small Molecule RXFP3/4 Agonist, Increasing Food Intake in Rats Upon Acute Central Administration
More description
|
|
| DCC4531 | Rx-111 |
Novel small molecule inhibitor of protein interaction with glycosaminoglycans (SMIGs), exercising broad spectrum anti-inflammatory activity by inhibition of protein binding to the cell surface GAG, heparan sulfate
More description
|
|
| DCC4530 | Rwj-60475 |
Novel CD45 phosphatase inhibitor
More description
|
|
| DCC4529 | rwj-58259 |
Selective antagonist of protease activated receptor-1
More description
|
|
| DCC4528 | Rwj-51204 |
Potent and selective of the benzodiazepine site on GABA(A) receptors
More description
|
|
| DCC4527 | Rwj50271 |
Inhibitor of LFA-1/ICAM-1 Mediated Cell Adhesion
More description
|
|
| DCC4526 | Rvd2n-3 Dpa |
Natural potent macrophage uptake enhancer of S. aureus and zymosan A bioparticles
More description
|
|
| DCC4525 | Ruvbl1/2-in-b |
Novel specific RUVBL1/2 ATPase inhibitor, radiosensitizing NSCLC, but not normal lung epithelial cells
More description
|
|
| DCC4524 | rutaecarpine-17 |
Inhibitor of Adipogenesis/Lipogenesis with AMPK Activation and UPR Suppression, Reducing Lipid Accumulation in Adipocytes
More description
|
|
| DCC4523 | Ru-nt-93 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|
| DCC4522 | Ru-nt-75 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|
| DCC4521 | Ru-nt-70 |
Novel Ricin Inhibitor, Targeting Ribosome Binding
More description
|
|